Evidence map›Paper›PMID 42325848›Full record

ArticleTobacco induced diseases2026

Marketing by online tobacco retailers: An observational cross-sectional study.

Dorie E Apollonio, Cathi E Dennehy, Candy Tsourounis, Tanner Wakefield

Abstract read
In one paragraph

Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dorie E ApollonioSchool of Pharmacy, University of California, San Francisco, United States.
Cathi E DennehySchool of Pharmacy, University of California, San Francisco, United States.
Candy TsourounisSchool of Pharmacy, University of California, San Francisco, United States.
Tanner WakefieldSchool of Medicine, University of California, San Francisco, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUnderstanding retailer advertising has been identified as critical for developing effective policies to reduce tobacco product use, as these forms of advertising are among the tobacco industry's largest expenditures. Online retailer marketing has grown rapidly, and in this study, we sought to describe the marketing practices of these retailers.

methodsBetween March and July 2022, we conducted keyword searches (e.g. 'buy e-cigs', 'buy vapes') with the Brave search engine, embedded in the Brave browser, to identify online tobacco retailers, using the inclusion criteria: English-language websites of online retailers selling e-cigarette products that allowed online ordering and the sale of products to customers in the United States. Measures included name, address, and landing page characteristics, including products, brands, product types, seasonal specials, social media links, age gating, and whether the retailer sold non-tobacco products. Results are reported descriptively.

resultsWe identified 97 unique online tobacco retailers. Of these, 58 (60%) had set a restriction on browsing based on age. E-cigarettes, both disposable and reusable, were the most available products, followed by liquid nicotine ('vape juice'). Thirty-seven percent of online tobacco retailers sold cannabis products, and 38% of retailer websites listed other types of products for sale (e.g. bongs, dab rigs, cannabis apparel, psilocybin chocolates).

conclusionsOur findings indicated that online tobacco retailers heavily marketed flavored products, and a majority sold derived cannabis products. Future research should continue to investigate whether this marketing conflicts with stated federal regulatory goals, and whether the U.S. Food and Drug Administration should expand enforcement of existing regulations on tobacco and derived cannabis products.

Indexed as

cannabismarijuanamarketingtobacco

Identifiers

PMID42325848
PMCPMC13280932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.